Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Return on Equity [ROE] (2016 - 2023)

Updated

Cartesian Therapeutics (RNAC) posted Return on Equity [ROE] of -61.96% for Q3 2023, down 93.79 percentage points from 31.84% a year earlier and down 7.89 percentage points from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Return on Equity [ROE] (2016 - 2023) Analysis & Trends

For FY2022, Cartesian Therapeutics' Return on Equity [ROE] came in at 60.82%, up 1198.67 percentage points from FY2021.

  • Annual Return on Equity [ROE] shows a five-year change of +181.40 percentage points (FY2017 to FY2022).
  • In prior years, Cartesian Therapeutics' Return on Equity [ROE] was -1137.85% in FY2021, -3716.01% in FY2019 (-3433.81 pp) and -282.21% in FY2018 (-161.62 pp).
  • The Q3 2023 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2021.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of +139.83 percentage points over the last four quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2019, with a gain of 3547.13 percentage points; the weakest was Q4 2018, with a drop of 6489.25 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -54.07% (Q2 2023), -7.73% (Q1 2023) and 23.98% (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -57.63%
Jun 30, 2023 -50.23%
Mar 31, 2023 -17.85%
Dec 31, 2022 39.60%
Sep 30, 2022 47.85%
Jun 30, 2022 43.75%
Mar 31, 2022 70.66%
Dec 31, 2021 -1,355.67%
Dec 31, 2019 -3,177.25%
Jun 30, 2019 -795.55%
Mar 31, 2019 -1,311.71%
Dec 31, 2018 -6,600.10%
Sep 30, 2018 -483.98%
Jun 30, 2018 -227.44%
Mar 31, 2018 -145.59%
Dec 31, 2017 -111.60%
Sep 30, 2017 -83.37%
Jun 30, 2017 -88.44%
Mar 31, 2017 -90.57%
Dec 31, 2016 -59.37%
API Access

Cartesian Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEY